Clarissa Naftzger

Title: Clarissa Naftzger: Innovator in Immune Response Stimulation

Introduction

Clarissa Naftzger is a prominent inventor based in San Carlos, CA (US). She has made significant contributions to the field of immunology, particularly in the development of methods to stimulate immune responses against differentiation antigens. Her innovative work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

Clarissa Naftzger holds a patent for a method and compositions for the stimulation of an immune response to a differentiation antigen. This patent outlines a therapeutic approach where the immune system's tolerance for self-differentiation antigens can be overcome. The therapeutic differentiation antigen can be altered in various ways to effectively stimulate an immune response in individuals being treated. This innovative method has the potential to enhance immunity against cancer by utilizing altered antigens.

Career Highlights

Naftzger is affiliated with the Sloan-Kettering Institute for Cancer Research, where she conducts her research and development. Her work focuses on advancing the understanding of immune responses and developing therapeutic strategies to combat cancer. With her expertise, she has contributed to the scientific community's knowledge of immunology and cancer treatment.

Collaborations

Clarissa Naftzger has collaborated with notable colleagues, including Alan N Houghton and Setaluri Vijayasaradhi. These collaborations have further enriched her research and have led to advancements in the field of cancer immunotherapy.

Conclusion

Clarissa Naftzger is a trailblazer in the field of immunology, with her innovative patent and research contributing to the fight against cancer. Her work at the Sloan-Kettering Institute for Cancer Research exemplifies her commitment to advancing medical science and improving patient outcomes.